Abstract
Despite decades of research, a dedicated international study organisation, guidelines recommending tighter glycaemic control and technological advances in glycaemic monitoring, women with PGDM still experience increased adverse maternal and fetal outcomes (including congenital malformations, miscarriage, preterm delivery, pre-eclampsia, macrosomia and perinatal mortality).
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
